Solar Industries India shares achieved a new all-time high of ₹17,962.05 on June 18, 2026, representing a 3.52% intraday gain and outperforming the broader market significantly. The stock demonstrated exceptional momentum with a 12.26% cumulative return over four consecutive days, significantly outperforming the Sensex which declined 9.74% during the same period. According to latest reports, the stock has delivered remarkable returns across all timeframes, with a 42.16% year-to-date return compared to the Sensex's 12.73% loss, and a 363.32% three-year return versus the Sensex's 21.06%. The stock's performance reflects sustained earnings growth with a five-year compound annual growth rate (CAGR) of 31.56% in net sales and 43.45% in operating profit (EBIT).
Elara Securities raised its target price to ₹21,290 from ₹15,450 earlier, valuing the stock at 65x March FY28E earnings versus 55x earlier. As reported by Business Standard, the assigned target price implies an 18.60% upside from the current market price. The brokerage highlighted that SOIL is present in all four categories with proven capability in three out of four segments, making it a major beneficiary of global defence spending. However, the stock carries a premium valuation with a trailing twelve months (TTM) price-to-earnings (P/E) ratio of 108 times and price-to-book value (P/BV) ratio of 30.7 times, reflecting very expensive valuations despite strong fundamentals. Despite the strong price appreciation, the stock trades at a premium valuation with a PEG ratio of 3.7, indicating that price growth has outpaced earnings growth.
The company delivered robust quarterly results with revenue rising 41% year-on-year to ₹3,052.75 crore, marking the highest quarterly revenue in the company's history. According to latest reports, Ebitda stood at ₹825.97 crore, up 53% Y-o-Y, while margins expanded 210 basis points Y-o-Y to 27.1%. PAT rose 72% Y-o-Y to ₹547.63 crore, with the strong performance driven by better gross margins and execution of defence and international business orders. The company has declared positive results for eight consecutive quarters, with the latest quarterly figures showing the highest-ever PAT of ₹547.63 crore and net sales of ₹3,052.75 crore. Earnings per share (EPS) surged to ₹60.51, the highest quarterly figure recorded, signalling strong returns for shareholders.
Defence revenue, contributing 33% to Q4 revenue, surged 134% Y-o-Y to ₹1,000 crore and continues to be a major growth driver. As reported by Business Standard, the international business, also contributing 33% to revenue, rose 32% to ₹1,060 crore. The company's order book stood at ₹21,300 crore, of which around ₹18,000 crore is defence-related, mainly driven by Pinaka orders and upcoming opportunities in similar systems. The company's annual sales of ₹8,951.54 crore account for 5.40% of the sector's total sales, while maintaining a large-cap market capitalisation of ₹1,57,015 crores, representing 23.98% of the entire Other Chemical products industry.
The stock's technical landscape remains broadly positive with multiple indicators supporting continued strength. On the weekly timeframe, the Moving Average Convergence Divergence (MACD) is bullish, confirming upward momentum, while the Bollinger Bands have expanded, suggesting increased volatility in the direction of the rally. The Know Sure Thing (KST) oscillator also supports this trend with a weekly bullish reading, reinforcing the momentum. The stock's ability to maintain gains above all major moving averages while the broader market struggles below key levels highlights its relative strength. However, on the monthly timeframe, mild bearishness in MACD and KST indicators suggests some caution in longer-term momentum, though the Relative Strength Index (RSI) on both weekly and monthly charts does not currently signal overbought or oversold conditions, providing room for further price movement. The On-Balance Volume (OBV) indicator is mildly bullish on both timeframes, indicating that volume trends are supporting the price advances.
